Quadrant Capital »

Aldeyra Therapeutics shares owned by Quadrant Capital

Quarter-by-quarter ownership of Aldeyra Therapeutics (ALDX) shares owned by Quadrant Capital from 13F filings

Historical chart of Quadrant Capital investment in Aldeyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aldeyra Therapeutics held by Quadrant Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aldeyra Therapeutics by Quadrant Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $965 185 5.22

More positions owned by Quadrant Capital

Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Schwab Strategic Tr Fundamental Us L (FNDX)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Core Msci Eafe (IEFA)
Amazon (AMZN)
Ishares Tr Core S&p Mcp Etf (IJH)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Procter & Gamble Company (PG)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)

View all positions for Quadrant Capital

Top funds holding Aldeyra Therapeutics

Knoll Capital Management
Perceptive Advisors
BlackRock
Vanguard Group
Ardsley Advisory Partners
AQR Capital Management
D. E. Shaw & Co
Kingdon Capital Management
Geode Capital Management
Kennedy Capital Management
State Street Corporation
Jacobs Levy Equity Management
Acadian Asset Management
683 Capital Management
Morgan Stanley

View all funds holding Aldeyra Therapeutics